Stealth nanoemulsions evade intestinal lipolysis and improve drug absorption after oral administration

• In: SUBMITTED APSA ORALS on Tuesday, 15 April 2014, 14:30-15:30
• At: PSWC, Melbourne (Australia) (2014)
• Type: Presentation
• By: FEENEY, Orlagh (Monash Institute of Pharmaceutical Sciences, Drug Delivery Disposition and Dynamics, Melbourne, Australia)
• Abstract:

  I. Background
  For over 20 years stealth drug delivery has been synonymous with nanoparticulate formulations and intravenous dosing. These formulations evade recognition by the immune system by preventing nonspecific protein binding and opsonisation. The current study examined the potential utility of stealth in oral drug delivery, specifically, to ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login